All In Biotech

Drug Trial Radar · NCT01016834

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated With Triptans

Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

246

Actual

Start

Nov 30, 2009

Primary completion

Apr 30, 2010

Study completion Apr 30, 2010

Sponsor

Lead sponsor
Zogenix, Inc.Industry
Sponsor type
Industry
Collaborators
Synteract, Inc.
First posted
Nov 20, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.

Conditions

  • Migraine

Interventions

  • Sumavel DoseProDevice

    Needle free delivery system containing 0.5 mL of solution of 6 mg sumatriptan, subcutaneous administration

  • SumatriptanDrug

    subcutaneous injection, 6 mg, per migraine attack, no more than two administrations within a 24 hr period

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Treatment Satisfaction at the End of the TreatmentTime frame: At the end of the treatment (after 4 migraines or 60 days, whichever came first)

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Hospital, Dept. of Neurology

    Birmingham, Alabama

  • Arizona Research Center

    Phoenix, Arizona

  • C. Phillip O'Carroll, MD, Inc

    Newport Beach, California

  • California Medical Clinic for Headache

    Santa Monica, California

  • Alpine Clinical Research

    Boulder, Colorado

  • University Clinical Research Inc.

    Pembroke Pines, Florida

  • Comprehensive Neuroscience Inc

    St. Petersburg, Florida

  • Comprehensive Neurosciences Inc

    Atlanta, Georgia

  • Neurology Specialists of Decatur

    Decatur, Georgia

  • Diamond Headache Clinic

    Chicago, Illinois

  • Michigan Head, Pain, & Neurological Institute

    Ann Arbor, Michigan

  • Clinvest/A Division of Banyan Group, Inc

    Springfield, Missouri

  • Mercy Health Research

    St Louis, Missouri

  • Meridian Clinical Research

    Omaha, Nebraska

  • Regional Clinical Research Inc

    Endwell, New York

  • Headache Wellness Center

    Greensboro, North Carolina

  • Cleveland Clinic: Neurological Center for Pain

    Cleveland, Ohio

  • Jefferson Headache Center

    Philadelphia, Pennsylvania

  • Neurological Medicine

    Clarksville, Tennessee

  • Nashville Neuroscience Group

    Nashville, Tennessee

  • Swedish Pain and Headache Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.